Bain Capital Raises $720M For New Life Sciences Fund

May 23 2017 | 9:42pm ET

Bain Capital has amassed $720 million for its first investment fund to exclusively focus on opportunities in the life sciences sector.

The new fund, named Bain Capital Life Sciences, will be led by former Biogen strategy executive Adam Koppel and invest between $30 and $70 million into private and public live sciences companies engaged in everything from medical devices to specialty pharmaceuticals and biotech, according to a Reuters article. Portfolio companies are expected to be at various stages of development, including clinical trials, expansion following regulatory approvals, or turnarounds.

The new fund will also partner with Bain Capital’s private equity funds to participate in leveraged buyouts, the article continued, although it will not typically take controlling stakes. $600 million of the total was raised from outside investors, with the remainder reportedly raised from Bain partners. 

“We are excited by some of the long-term secular trends in the life sciences space,” said Koppel to Reuters. “Big pharma is increasingly outsourcing R&D at the same time as many new technologies and treatments are being developed.”

Two investments have already been made from the new vehicle, the article continued, into development-stage companies Dicerna Pharmaceuticals and Solid Biosciences.

Based in Boston and founded in 1984 by former U.S. presidential candidate and governor of Massachusetts Mitt Romney with partners from consulting firm Bain & Co., Bain Capital is one of Wall Street’s largest remaining closely-held partnerships. The company manages approximately $75 billion across private equity, venture capital, credit and public equity strategies. 


In Depth

Q&A: Portfolio Advisors' Brian Murphy On The Advantages of A Private Markets Platform

Jan 2 2018 | 11:05am ET

Most private markets firms reference their platforms as a source of competitive...

Lifestyle

CFA Institute To Add Computer Science To Exam Curriculum

May 24 2017 | 9:25pm ET

Starting in 2019, financial industry executives sitting for the coveted Chartered...

Guest Contributor

Steinbrugge: The Top Hedge Fund Industry Trends for 2018

Jan 2 2018 | 12:22pm ET

Each year, Don Steinbrugge’s Agecroft Partners compiles the insights gained...

 

FINalternatives Trending

From the current issue of